Daniel E. Maddox

1.2k total citations
25 papers, 825 citations indexed

About

Daniel E. Maddox is a scholar working on Rheumatology, Physiology and Surgery. According to data from OpenAlex, Daniel E. Maddox has authored 25 papers receiving a total of 825 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Rheumatology, 8 papers in Physiology and 6 papers in Surgery. Recurrent topics in Daniel E. Maddox's work include Asthma and respiratory diseases (6 papers), Eosinophilic Esophagitis (5 papers) and Eosinophilic Disorders and Syndromes (5 papers). Daniel E. Maddox is often cited by papers focused on Asthma and respiratory diseases (6 papers), Eosinophilic Esophagitis (5 papers) and Eosinophilic Disorders and Syndromes (5 papers). Daniel E. Maddox collaborates with scholars based in United States and Mexico. Daniel E. Maddox's co-authors include John B. Hagan, Miguel A. Park, James T. Li, Roshini S. Abraham, Shohei Shibata, Ido Goldstein, James T.C. Li, Gerald J. Gleich, Joseph H. Butterfield and William F. Young and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and The Journal of Experimental Medicine.

In The Last Decade

Daniel E. Maddox

24 papers receiving 791 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel E. Maddox United States 13 312 174 133 126 111 25 825
Patricia Rohane United States 9 360 1.2× 226 1.3× 87 0.7× 266 2.1× 80 0.7× 10 981
Francesca Nencini Italy 17 396 1.3× 179 1.0× 57 0.4× 117 0.9× 85 0.8× 51 901
G. Ed Rainger United Kingdom 13 423 1.4× 173 1.0× 121 0.9× 119 0.9× 71 0.6× 19 1.3k
Hedy Smith United States 16 535 1.7× 117 0.7× 82 0.6× 85 0.7× 37 0.3× 38 1.2k
A Corvetta Italy 15 195 0.6× 75 0.4× 53 0.4× 71 0.6× 66 0.6× 36 763
Alessio Mazzoni Italy 19 500 1.6× 70 0.4× 96 0.7× 95 0.8× 48 0.4× 51 1.2k
Alastair Hansen Denmark 20 118 0.4× 292 1.7× 239 1.8× 171 1.4× 178 1.6× 52 1.3k
Yvonne Linde Germany 9 493 1.6× 60 0.3× 100 0.8× 63 0.5× 58 0.5× 10 910
Silvia Giannini Italy 22 256 0.8× 197 1.1× 136 1.0× 205 1.6× 28 0.3× 39 1.6k
Felice Rivellese United Kingdom 21 713 2.3× 162 0.9× 117 0.9× 78 0.6× 94 0.8× 54 1.4k

Countries citing papers authored by Daniel E. Maddox

Since Specialization
Citations

This map shows the geographic impact of Daniel E. Maddox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel E. Maddox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel E. Maddox more than expected).

Fields of papers citing papers by Daniel E. Maddox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel E. Maddox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel E. Maddox. The network helps show where Daniel E. Maddox may publish in the future.

Co-authorship network of co-authors of Daniel E. Maddox

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel E. Maddox. A scholar is included among the top collaborators of Daniel E. Maddox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel E. Maddox. Daniel E. Maddox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McDonald, Jennifer S., Nicholas B. Larson, Amy B. Kolbe, et al.. (2021). Prevention of Allergic-like Reactions at Repeat CT: Steroid Pretreatment versus Contrast Material Substitution. Radiology. 301(1). 133–140. 31 indexed citations
2.
Neth, Bryan J., Michael W. Ruff, Joon H. Uhm, et al.. (2020). Temozolomide desensitization followed by metronomic dosing in patients with hypersensitivity. Cancer Chemotherapy and Pharmacology. 86(3). 375–382. 1 indexed citations
3.
McDonald, Jennifer S., Christopher H. Hunt, Amy B. Kolbe, et al.. (2019). Acute Adverse Events Following Gadolinium-based Contrast Agent Administration: A Single-Center Retrospective Study of 281 945 Injections. Radiology. 292(3). 620–627. 50 indexed citations
4.
Kolbe, Amy B., Robert P. Hartman, Tanya L. Hoskin, et al.. (2014). Premedication of patients for prior urticarial reaction to iodinated contrast medium. Abdominal Imaging. 39(2). 432–437. 22 indexed citations
5.
Barbara, David W., et al.. (2013). Perioperative angioedema: background, diagnosis, and management. Journal of Clinical Anesthesia. 25(4). 335–343. 12 indexed citations
6.
Larenas‐Linnemann, Désirée, et al.. (2011). Maintenance dosing for sublingual immunotherapy by prominent European allergen manufacturers expressed in bioequivalent allergy units. Annals of Allergy Asthma & Immunology. 107(5). 448–458.e3. 37 indexed citations
7.
Leung, Nelson, Alfonso Eirin, María V. Irazabal, et al.. (2009). Acute Kidney Injury in Patients with Inactive Cytochrome P450 Polymorphisms. Renal Failure. 31(8). 749–752. 11 indexed citations
8.
Park, Miguel A., James T. Li, John B. Hagan, Daniel E. Maddox, & Roshini S. Abraham. (2008). Common variable immunodeficiency: a new look at an old disease. The Lancet. 372(9637). 489–502. 226 indexed citations
9.
Park, Miguel A., James T. Li, John B. Hagan, Daniel E. Maddox, & Roshini S. Abraham. (2008). Common variable immunodefi ciency: a new look at an old disease. 6 indexed citations
10.
Cherry, William B., et al.. (2007). Omalizumab Therapy in Evolving Allergic Bronchopulmonary Aspergillosis. Journal of Allergy and Clinical Immunology. 119(1). S211–S211. 2 indexed citations
11.
Matešić, Damir, Evangelo Frigas, Hirohito Kita, et al.. (2005). Comparison of an in-house preparation of the major allergenic determinant of benzyl penicillin G With the commercially produced Pre-Pen. Journal of Allergy and Clinical Immunology. 115(2). S182–S182. 2 indexed citations
12.
Maddox, Daniel E., et al.. (2003). Vaccine allergy: diagnosis and management. Immunology and Allergy Clinics of North America. 23(4). 555–588. 24 indexed citations
13.
Dellen, Richard G. Van, et al.. (2002). Masqueraders of angioedema and urticaria. Annals of Allergy Asthma & Immunology. 88(1). 10–15. 12 indexed citations
14.
Maddox, Daniel E., et al.. (1999). Systemic reactions to allergy skin tests. Annals of Allergy Asthma & Immunology. 83(2). 132–136. 74 indexed citations
15.
Young, William F. & Daniel E. Maddox. (1995). Spells: In Search of a Cause. Mayo Clinic Proceedings. 70(8). 757–765. 42 indexed citations
16.
Maddox, Daniel E., G M Kephart, Carolyn B. Coulam, et al.. (1984). Localization of a molecule immunochemically similar to eosinophil major basic protein in human placenta.. The Journal of Experimental Medicine. 160(1). 29–41. 60 indexed citations
17.
Butterfield, Joseph H., Daniel E. Maddox, & Gerald J. Gleich. (1984). The eosinophil leukocyte: maturation and function.. PubMed. 2(2). 187–306. 15 indexed citations
18.
Maddox, Daniel E., Joseph H. Butterfield, S.J. Ackerman, Carolyn B. Coulam, & Gerald J. Gleich. (1983). Elevated serum levels in human pregnancy of a molecule immunochemically similar to eosinophil granule major basic protein.. The Journal of Experimental Medicine. 158(4). 1211–1226. 52 indexed citations
19.
Maddox, Daniel E., Shohei Shibata, & Ido Goldstein. (1982). Stimulated macrophages express a new glycoprotein receptor reactive with Griffonia simplicifolia I-B4 isolectin.. Proceedings of the National Academy of Sciences. 79(1). 166–170. 120 indexed citations
20.
Maddox, Daniel E., Irwin Goldstein, & Albert F. LoBuglio. (1982). Griffonia simplicifolia I lectin mediates macrophage-induced cytotoxicity against Ehrlich ascites tumor. Cellular Immunology. 71(1). 202–207. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026